Published in J Hypertens on January 01, 2014
Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Acta Diabetol (2014) 1.48
Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study. Am J Hypertens (2014) 1.48
Serum uric acid as a prognostic marker in the setting of advanced vascular disease: a prospective study in the elderly. J Geriatr Cardiol (2015) 0.90
Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. J Hypertens (2015) 0.80
Serum uric acid level, blood pressure, and vascular angiotensin II responsiveness in healthy men and women. Physiol Rep (2014) 0.79
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study. J Am Heart Assoc (2017) 0.77
Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging. Hypertension (2016) 0.76
Peripheral arterial stiffness is associated with higher baseline plasma uric acid: A prospective cohort study. Saudi J Biol Sci (2017) 0.75
Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study. Medicine (Baltimore) (2016) 0.75
Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association. Curr Hypertens Rep (2017) 0.75
Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population. PLoS One (2017) 0.75
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation (2009) 3.39
Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol (2010) 2.54
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29
The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk. Intern Emerg Med (2011) 2.12
Reference values of pulse wave velocity in healthy children and teenagers. Hypertension (2010) 1.91
Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension (2009) 1.69
Reference values of aortic pulse wave velocity in the elderly. J Hypertens (2008) 1.60
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med (Hagerstown) (2014) 1.50
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Idiopathic sudden hearing loss: another kind of circulatory risk should not be neglected. Eur Arch Otorhinolaryngol (2013) 1.39
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk. Cardiovasc Drugs Ther (2005) 1.39
Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study. Intern Emerg Med (2013) 1.39
Could statins exert a protective effect on epistaxis of systemic origin? Med Hypotheses (2010) 1.38
Systolic and diastolic pulse wave velocity: a confusing parameter or a new frontier? J Hypertens (2012) 1.37
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol (2011) 1.25
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol (2011) 1.13
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens (2012) 1.04
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health (2010) 0.99
Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens (2006) 0.97
Pulse wave velocity is associated with 1-year cognitive decline in the elderly older than 80 years: the PARTAGE study. J Am Med Dir Assoc (2010) 0.97
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. BMC Public Health (2011) 0.96
Central hemodynamic modifications in diabetes mellitus. Atherosclerosis (2013) 0.96
Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens (2007) 0.95
Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr Res (2013) 0.93
Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens (2010) 0.93
Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol (2009) 0.90
Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens (2012) 0.90
Measurement of pulse wave velocity in children and young adults: a comparative study using three different devices. Hypertens Res (2011) 0.90
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag (2007) 0.90
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate. Arch Med Sci (2013) 0.89
Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study. BMC Cardiovasc Disord (2010) 0.88
Inner ear symptoms: can we use them to approach cardiovascular diseases? Intern Emerg Med (2014) 0.88
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium (2007) 0.88
Cardiometabolic Risks and Obesity in the Young. N Engl J Med (2016) 0.88
Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects. Arch Med Sci (2012) 0.87
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev (2013) 0.86
Pulse pressure amplification, pressure waveform calibration and clinical applications. Atherosclerosis (2012) 0.86
Blood pressure regulation during the aging process: the end of the 'hypertension era'? J Hypertens (2011) 0.86
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials. Curr Opin Cardiol (2002) 0.85
Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens (2013) 0.85
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens (2010) 0.84
Simultaneous measurement of beat-to-beat carotid diameter and pressure changes to assess arterial mechanical properties. Hypertension (2008) 0.84
[Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project]. G Ital Cardiol (Rome) (2007) 0.84
Zofenopril and incidence of cough: a review of published and unpublished data. Ther Clin Risk Manag (2011) 0.84
Long-term effect of a dietary education program on postmenopausal cardiovascular risk and metabolic syndrome: the Brisighella Heart Study. J Womens Health (Larchmt) (2010) 0.83
Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals. Curr Hypertens Rep (2013) 0.82
Relationship between serum uric acid and electrocardiographic alterations in a large sample of general population: data from the Brisighella Heart Study. High Blood Press Cardiovasc Prev (2014) 0.82
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. Blood Press (2009) 0.82
Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study. Intern Emerg Med (2014) 0.81
Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study. J Hypertens (2010) 0.81
Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens (2013) 0.81
How to avoid the depression of the adherence to antihypertensive treatment? J Hypertens (2013) 0.81
Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort. Obes Facts (2012) 0.80
Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: a 12-years follow-up of the Brisighella Heart Study historical cohort. Diabetes Res Clin Pract (2014) 0.80
Correlation between peripheral blood pressure and pulse-wave velocity values in the institutionalized elderly persons 80 years of age and older: the PARTAGE study. Am J Hypertens (2012) 0.80
Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control. High Blood Press Cardiovasc Prev (2013) 0.80
Heart disease and changes in pulse wave velocity and pulse pressure amplification in the elderly over 80 years: the PARTAGE Study. J Hypertens (2010) 0.80
The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial. J Clin Hypertens (Greenwich) (2013) 0.80
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure. Eur Heart J (2012) 0.79
C-reactive protein levels in patients at cardiovascular risk: EURIKA study. BMC Cardiovasc Disord (2014) 0.79
Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome. Eur J Cardiovasc Prev Rehabil (2009) 0.79
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens (2007) 0.79
Could echocardiography yield a cardiovascular profile of the tinnitus prone subject? Med Hypotheses (2007) 0.79
Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study. J Cardiovasc Med (Hagerstown) (2012) 0.79
Global cardiovascular disease risk management in italian patients with metabolic syndrome in the clinical practice setting. High Blood Press Cardiovasc Prev (2013) 0.78
Population health needs assessment and healthcare services use in a 3 years follow-up on administrative and clinical data: results from the Brisighella Heart Study. High Blood Press Cardiovasc Prev (2013) 0.78
Continuous ultrafiltration for congestive heart failure: the CUORE trial. J Card Fail (2014) 0.78
Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study. Int J Cardiol (2011) 0.78
Evidence of catalase mimetic activity in Ce(3+)/Ce(4+) doped bioactive glasses. J Phys Chem B (2015) 0.78
Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study. Int J Endocrinol (2011) 0.78
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway. Eur Neurol (2015) 0.78
Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial. J Med Food (2010) 0.78
Lipoprotein(a) and other serum lipid subfractions influencing primary patency after infrainguinal percutaneous transluminal angioplasty. J Endovasc Ther (2009) 0.78
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects. J Lipid Res (2012) 0.78
A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs (2015) 0.78
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: an epidemiological approach. J Inherit Metab Dis (2007) 0.78
Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects. Ann Nutr Metab (2016) 0.78
Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. Intern Emerg Med (2012) 0.78
Assessment and interpretation of blood pressure variability in a clinical setting. Blood Press (2013) 0.78